Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine Initiative Against Alzheimer's Disease (PMIAAD): Digitally-enhanced, Decentralized, Multi-omics, Observational Cohort

NCT04701177 is registered in ClinicalTrials.gov with Greece 2021 Committee as lead sponsor.

NCT NCT04701177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine Initiative Against Alzheimer's Disease (PMIAAD): Digitally-enhanced, Decentralized, Multi-omics, Observational Cohort
Lead sponsor
Greece 2021 Committee
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 15, 2021
Completion date
November 30, 2031
Enrollment
100,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive change, dementia, memory loss (excluding dementia), mild cognitive impairment, parkinson's disease and parkinsonism, presymptomatic disease